Immune Checkpoint Inhibitors for the Treatment of Bladder Cancer.
Saved in:
| Title: | Immune Checkpoint Inhibitors for the Treatment of Bladder Cancer. |
|---|---|
| Authors: | Lopez-Beltran A; Unit of Anatomic Pathology, Department of Morphological Sciences, Cordoba University Medical School, 14004 Cordoba, Spain., Cimadamore A; Pathological Anatomy, School of Medicine, United Hospitals, Polytechnic University of the Marche Region, 60126 Ancona, Italy., Blanca A; Maimonides Biomedical Research Institute of Cordoba, Department of Urology, University Hospital of Reina Sofia, 14004 Cordoba, Spain., Massari F; Division of Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy., Vau N; Medical Oncology, Champalimaud Clinical Center, 1400-038 Lisbon, Portugal., Scarpelli M; Pathological Anatomy, School of Medicine, United Hospitals, Polytechnic University of the Marche Region, 60126 Ancona, Italy., Cheng L; Department of Pathology and Laboratory Medicine, School of Medicine, Indiana University, Indianapolis, IN 46202, USA., Montironi R; Pathological Anatomy, School of Medicine, United Hospitals, Polytechnic University of the Marche Region, 60126 Ancona, Italy. |
| Source: | Cancers [Cancers (Basel)] 2021 Jan 03; Vol. 13 (1). Date of Electronic Publication: 2021 Jan 03. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
